1. The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events
   Jie Dou et al, 2024, Asian Journal of Surgery CrossRef
2. Efficacy and Safety of a Pharmaco-Invasive Strategy Using Half-Dose Recombinant Human Prourokinase in Patients with ST-Segment Elevation Myocardial Infarction During Hospitalization
   Jie Dou et al, 2024, Clinical and Applied Thrombosis/Hemostasis CrossRef